In this sector wrap, we highlight our key takeaways from the recent Insurance and Diversified Financials reporting season. Overall, it proved to be a strong reporting season across the board, with most company results meeting or beating expectations. While there were some disappointments—most notably NHF’s challenging results and slightly softer guidance from QBE and PXA—our focus remains on several standout picks: QBE, SUN, and CGF.

QBE Insurance Group (QBE)

QBE’s 1H24 result was broadly in-line at both Gross Written Premium (GWP) and NPAT, with the company delivering a solid 16.9% ROE (10.1% in the pcp). Overall we saw this result as largely as expected, with the negative being slightly lowered FY24 top-line guidance, and the positive being an improved overall North America business performance. We lower our QBE FY24F/FY25 EPS by 9%/5% reflecting; restructuring charges, reduced top-line growth expectations, higher tax rate forecasts and a change in QBE’s definition of adjusted NPAT. We continue see QBE as too cheap, trading on 10x FY24F PE.

Outlook commentary:

FY24 guidance is now for constant currency GWP growth of 3% (previously mid-single-digit), and a combined operating ratio of 93.5% (which is unchanged).

Suncorp Group (SUN)

SUN’s FY24 cash NPAT (A$1,372m) was ~-5% below consensus (A$1,425m), mainly due to a softer General Insurance result than expected. FY25 guidance points to solid earnings momentum continuing into this year, and we see SUN’s unveiled FY25-FY27 business strategy as uncomplicated and focused on driving the insurance business harder (which should be well received). We lift our SUN FY25F/FY26F EPS by 5-6% on an increase in insurance margin forecasts and lower “other items” forecasts.

Outlook commentary:

  • GWP growth expected to be in the mid to high single digits, primarily driven by increases in AWP albeit with moderating premium rates as the reinsurance market stabilises and inflationary pressures ease slightly in some portfolios.
  • Investment yields are expected to reduce as market expectations for interest rates decline in anticipation of a stabilisation in inflation. For FY25, prior year reserve releases in CTP are expected to be around 0.4% of Group net insurance revenue, with releases in other portfolios expected to be neutral over the year. An UITR towards the top of the 10% to 12% range is target.

Challenger Financial Svcs (CGF)

CGF’s FY24 normalised NPAT (A$417m) was in-line with consensus and +14% on the pcp. Overall, we saw this as a positive FY24 result highlighted by a strong improvement in Life business margins/returns, good group cost control and an upward step change in CGF’s capital position. We lift our CGF FY25F/FY26F EPS by 4%-6% on higher Life business margin expectations, and a reduction in our cost-to-income ratio forecasts. With CGF having good earnings momentum, and trading on an undemanding 12x FY25F PE multiple, we see further upside.

Outlook commentary:

  • In FY25, Challenger is targeting a normalised net profit after tax guidance between $440 million and $480 million, with the mid-point of the range representing a 10% increase on FY24.
  • Based on Challenger’s assumed FY25 effective tax rate of 31.3% this equates to a normalised NPBT guidance range of between $640 million and $700 million.
  • Challenger has also lowered its cost to income ratio target range to 32% to 34% from FY25 (previously 35%-37%). Challenger is on track to achieve its ROE target in FY25, which represents the mid-point for the FY25 earnings guidance range.

Morgans clients receive exclusive insights such as access to the latest stock and sector coverage featured in the Month Ahead. Contact us today to begin your journey with Morgans.

      
Contact Us
      

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

News & Insights

US Factory building boom keeps growth strong, but falling inflation means big Fed rate cuts still ahead.
Read full article
Investment Watch is a flagship product that brings together our analysts' view of economic and investment strategy themes, sector outlooks and best stock ideas for our clients.
Read full article
Most results were thereabouts against expectations which saw the sector perform broadly in line with the index. Top picks are ALQ and CVL.
Read full article

News & Insights

Overall, it proved to be a strong reporting season across the board, with most company results meeting or beating expectations. Our focus remains on several standout picks: QBE, SUN, and CGF.
Find out more